Yanai-Inamura H - Search Results

1

Urethral function and histopathology in aged female rats as a stress urinary incontinence model.

Yanai-Inamura H, Ohashi R, Ishigami T, Hirata T, Kumakura F, Kono G, Yokono M, Takeda M, Miyata K. Yanai-Inamura H, et al. Low Urin Tract Symptoms. 2019 Apr;11(2):O186-O192. doi: 10.1111/luts.12209. Epub 2017 Dec 20. Low Urin Tract Symptoms. 2019. PMID: 29266769

2

Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized rats.

Yanai-Inamura H, Ohtake A, Noguchi Y, Hatanaka T, Suzuki M, Ueshima K, Sato S, Sasamata M. Yanai-Inamura H, et al. Eur J Pharmacol. 2012 Mar 15;679(1-3):127-31. doi: 10.1016/j.ejphar.2012.01.019. Epub 2012 Feb 1. Eur J Pharmacol. 2012. PMID: 22314219

3

Zolpidem increases bladder capacity and decreases urine excretion in rats.

Yokoyama O, Matsuta Y, Yanai-Inamura H, Watanabe M, Ohtake A, Suzuki M, Sasamata M. Yokoyama O, et al. Among authors: yanai inamura h. Neurourol Urodyn. 2010 Apr;29(4):587-91. doi: 10.1002/nau.20797. Neurourol Urodyn. 2010. PMID: 19760758

4

In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Michel MC, Okutsu H, Noguchi Y, Suzuki M, Ohtake A, Yuyama H, Yanai-Inamura H, Ukai M, Watanabe M, Someya A, Sasamata M. Michel MC, et al. Among authors: yanai inamura h. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):346-53. doi: 10.1007/s00210-006-0034-9. Epub 2006 Feb 18. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16489448

5

Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.

Tsukamoto I, Koshio H, Kuramochi T, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Shimada Y, Sakamoto S, Tsukamoto S. Tsukamoto I, et al. Among authors: yanai inamura h. Bioorg Med Chem. 2009 Apr 15;17(8):3130-41. doi: 10.1016/j.bmc.2009.03.001. Epub 2009 Mar 9. Bioorg Med Chem. 2009. PMID: 19321349

6

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes.

Tsukamoto I, Koshio H, Orita M, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Sakamoto S, Tsukamoto S. Tsukamoto I, et al. Among authors: yanai inamura h. Bioorg Med Chem. 2009 Dec 15;17(24):8161-7. doi: 10.1016/j.bmc.2009.10.038. Epub 2009 Oct 23. Bioorg Med Chem. 2009. PMID: 19900813

7

Characterization of the pharmacology of YM-198313 on volume-regulated anion channels.

Shibata H, Satoh TO, Ugawa T, Masuda N, Yanai-Inamura H, Abe A, Kondo Y, Kuramochi T, Akamatsu S, Uchida W. Shibata H, et al. Among authors: yanai inamura h. Biol Pharm Bull. 2005 Jul;28(7):1187-91. doi: 10.1248/bpb.28.1187. Biol Pharm Bull. 2005. PMID: 15997095 Free article.

8

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.

Tsukamoto I, Koshio H, Akamatsu S, Kuramochi T, Saitoh C, Yatsu T, Yanai-Inamura H, Kitada C, Yamamoto E, Sakamoto S, Tsukamoto S. Tsukamoto I, et al. Among authors: yanai inamura h. Bioorg Med Chem. 2008 Nov 1;16(21):9524-35. doi: 10.1016/j.bmc.2008.09.039. Epub 2008 Sep 17. Bioorg Med Chem. 2008. PMID: 18835174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page